These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 20883838)
1. Injectable hyaluronic acid-tyramine hydrogels for the treatment of rheumatoid arthritis. Kim KS; Park SJ; Yang JA; Jeon JH; Bhang SH; Kim BS; Hahn SK Acta Biomater; 2011 Feb; 7(2):666-74. PubMed ID: 20883838 [TBL] [Abstract][Full Text] [Related]
2. An injectable hyaluronic acid-tyramine hydrogel system for protein delivery. Lee F; Chung JE; Kurisawa M J Control Release; 2009 Mar; 134(3):186-93. PubMed ID: 19121348 [TBL] [Abstract][Full Text] [Related]
3. Enzymatic conjugation of a bioactive peptide into an injectable hyaluronic acid-tyramine hydrogel system to promote the formation of functional vasculature. Wang LS; Lee F; Lim J; Du C; Wan AC; Lee SS; Kurisawa M Acta Biomater; 2014 Jun; 10(6):2539-50. PubMed ID: 24561710 [TBL] [Abstract][Full Text] [Related]
4. Effect of cross-linking reagents for hyaluronic acid hydrogel dermal fillers on tissue augmentation and regeneration. Yeom J; Bhang SH; Kim BS; Seo MS; Hwang EJ; Cho IH; Park JK; Hahn SK Bioconjug Chem; 2010 Feb; 21(2):240-7. PubMed ID: 20078098 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and degradation test of hyaluronic acid hydrogels. Hahn SK; Park JK; Tomimatsu T; Shimoboji T Int J Biol Macromol; 2007 Mar; 40(4):374-80. PubMed ID: 17101173 [TBL] [Abstract][Full Text] [Related]
6. Injectable hyaluronic acid-tyramine hydrogels incorporating interferon-α2a for liver cancer therapy. Xu K; Lee F; Gao SJ; Chung JE; Yano H; Kurisawa M J Control Release; 2013 Mar; 166(3):203-10. PubMed ID: 23328125 [TBL] [Abstract][Full Text] [Related]
7. Injectable Click-Crosslinked Hyaluronic Acid Depot To Prolong Therapeutic Activity in Articular Joints Affected by Rheumatoid Arthritis. Seo J; Park SH; Kim MJ; Ju HJ; Yin XY; Min BH; Kim MS ACS Appl Mater Interfaces; 2019 Jul; 11(28):24984-24998. PubMed ID: 31264830 [TBL] [Abstract][Full Text] [Related]
8. Injectable biodegradable hydrogels composed of hyaluronic acid-tyramine conjugates for drug delivery and tissue engineering. Kurisawa M; Chung JE; Yang YY; Gao SJ; Uyama H Chem Commun (Camb); 2005 Sep; (34):4312-4. PubMed ID: 16113732 [TBL] [Abstract][Full Text] [Related]
9. Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis. Roth A; Mollenhauer J; Wagner A; Fuhrmann R; Straub A; Venbrocks RA; Petrow P; Bräuer R; Schubert H; Ozegowski J; Peschel G; Müller PJ; Kinne RW Arthritis Res Ther; 2005; 7(3):R677-86. PubMed ID: 15899053 [TBL] [Abstract][Full Text] [Related]
10. Injectable hyaluronic acid microhydrogels for controlled release formulation of erythropoietin. Hahn SK; Kim JS; Shimobouji T J Biomed Mater Res A; 2007 Mar; 80(4):916-24. PubMed ID: 17072846 [TBL] [Abstract][Full Text] [Related]
11. Enzymatically-crosslinked injectable hydrogels based on biomimetic dextran-hyaluronic acid conjugates for cartilage tissue engineering. Jin R; Teixeira LS; Dijkstra PJ; van Blitterswijk CA; Karperien M; Feijen J Biomaterials; 2010 Apr; 31(11):3103-13. PubMed ID: 20116847 [TBL] [Abstract][Full Text] [Related]
12. Sustained release formulation of erythropoietin using hyaluronic acid hydrogels crosslinked by Michael addition. Hahn SK; Oh EJ; Miyamoto H; Shimobouji T Int J Pharm; 2006 Sep; 322(1-2):44-51. PubMed ID: 16781096 [TBL] [Abstract][Full Text] [Related]
13. Functionalization of hyaluronic acid with chemoselective groups via a disulfide-based protection strategy for in situ formation of mechanically stable hydrogels. Ossipov DA; Piskounova S; Varghese OP; Hilborn J Biomacromolecules; 2010 Sep; 11(9):2247-54. PubMed ID: 20704177 [TBL] [Abstract][Full Text] [Related]
14. Hyaluronidase-incorporated hyaluronic acid-tyramine hydrogels for the sustained release of trastuzumab. Xu K; Lee F; Gao S; Tan MH; Kurisawa M J Control Release; 2015 Oct; 216():47-55. PubMed ID: 26260452 [TBL] [Abstract][Full Text] [Related]
15. Growth inhibitory effect of an injectable hyaluronic acid-tyramine hydrogels incorporating human natural interferon-α and sorafenib on renal cell carcinoma cells. Ueda K; Akiba J; Ogasawara S; Todoroki K; Nakayama M; Sumi A; Kusano H; Sanada S; Suekane S; Xu K; Bae KH; Kurisawa M; Igawa T; Yano H Acta Biomater; 2016 Jan; 29():103-111. PubMed ID: 26481041 [TBL] [Abstract][Full Text] [Related]
16. Prolonged, staged, and self-regulated methotrexate release coupled with ROS scavenging in an injectable hydrogel for rheumatoid arthritis therapy. Xu M; Fu T; Zhang C; An Z; Yan J; Lu Z; Wu H; Liu J; Qiu L; Shi L; Lin J; Cao Y; Pei R J Control Release; 2024 Nov; 375():60-73. PubMed ID: 39216600 [TBL] [Abstract][Full Text] [Related]
17. Enhanced intra-articular therapy for rheumatoid arthritis using click-crosslinked hyaluronic acid hydrogels loaded with toll-like receptor antagonizing peptides. Lee S; Seo J; Kim YH; Ju HJ; Kim S; Ji YB; Lee HB; Kim HS; Choi S; Kim MS Acta Biomater; 2023 Dec; 172():188-205. PubMed ID: 37866726 [TBL] [Abstract][Full Text] [Related]
18. Enzyme-mediated hyaluronic acid-tyramine hydrogels for the propagation of human embryonic stem cells in 3D. Xu K; Narayanan K; Lee F; Bae KH; Gao S; Kurisawa M Acta Biomater; 2015 Sep; 24():159-71. PubMed ID: 26112373 [TBL] [Abstract][Full Text] [Related]
19. Extracellular matrix-mimetic composite hydrogels of cross-linked hyaluronan and fibrillar collagen with tunable properties and ultrastructure. Frayssinet A; Petta D; Illoul C; Haye B; Markitantova A; Eglin D; Mosser G; D'Este M; Hélary C Carbohydr Polym; 2020 May; 236():116042. PubMed ID: 32172856 [TBL] [Abstract][Full Text] [Related]
20. Hyaluronate-gold nanoparticle/tocilizumab complex for the treatment of rheumatoid arthritis. Lee H; Lee MY; Bhang SH; Kim BS; Kim YS; Ju JH; Kim KS; Hahn SK ACS Nano; 2014 May; 8(5):4790-8. PubMed ID: 24730974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]